A randomized placebo-controlled trial of adefovir dipivoxil in advanced HIV infection: the ADHOC trial.

OBJECTIVES: To assess the efficacy and safety of adefovir dipivoxil (ADV) added to stable background antiretroviral therapy (ART) in HIV-infected individuals with advanced HIV disease. METHODS: ADHOC was a randomized, double-blind, placebo-controlled, international multicentre trial. Three hundred...

Ful tanımlama

Detaylı Bibliyografya
Yazar: ADHOC International Steering Committee
Materyal Türü: Journal article
Dil:English
Baskı/Yayın Bilgisi: 2002

Benzer Materyaller